Picture of Aceragen logo

ACGN — Aceragen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Brief: Idera Pharmaceuticals Q2 Loss Per Share $0.59

Aug 2 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS REPORTS SECOND QUARTER 2018
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q2 LOSS PER SHARE $0.59
    * Q2 EARNINGS PER SHARE VIEW $-0.82 -- THOMSON REUTERS
I/B/E/S

Source text for Eikon:  ID:nGNX65mxk7 
Further company coverage:  IDRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aceragen

See all news